Literature DB >> 18046620

Change of body weight and lifestyle of persons at risk for diabetes after screening and counselling in pharmacies.

Andrea Botomino1, Rudolf Bruppacher, Stephan Krähenbühl, Kurt E Hersberger.   

Abstract

OBJECTIVE: To investigate the effects of pharmacy based counselling on changes in lifestyle and body weight.
METHODS: Three months after screening a stratified sample of 3,800 randomly chosen overweight persons were addressed with questionnaires. Half a year and 1 year later the assessment was repeated. Standard counselling (SC; non-specific recommendations towards lifestyle), intensive counselling (IC; additional advice to reduce body weight) and counselling for persons at high risk for type 2 diabetes (HRC; recommendation to contact a physician) were compared.
RESULTS: All counselling groups (SC; n = 557, IC; n = 568, HRC; n = 245) showed significant weight loss three months after screening (0.6-1.9 kg). A further weight reduction was observed at 1 year follow up (1.1-2.4 kg). The HRC group showed a higher percentage of weight loss than the IC or SC group after 3 months (-2.25% vs. -1.20% and -0.67%; P < 0.001) and at 1 year of follow-up (-2.74% vs. -1.54% and -1.29%; P < 0.01). Lifestyle changes in physical activity and/or nutrition were reported by 81.2% in the HRC group, 74.1% in the IC group and 67.0% in the SC group.
CONCLUSION: Immediate counselling in community pharmacies after screening for type 2 diabetes can result in significant lifestyle changes and weight loss in overweight individuals.

Entities:  

Mesh:

Year:  2007        PMID: 18046620     DOI: 10.1007/s11096-007-9174-3

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  10 in total

Review 1.  The transtheoretical model of health behavior change.

Authors:  J O Prochaska; W F Velicer
Journal:  Am J Health Promot       Date:  1997 Sep-Oct

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

3.  Seasonal fluctuation in body mass index.

Authors:  Alexander Dzien; Christine Dzien-Bischinger; Monika Lechleitner
Journal:  Clin Nutr       Date:  2003-08       Impact factor: 7.324

4.  Sequential screening for diabetes--evaluation of a campaign in Swiss community pharmacies.

Authors:  Kurt E Hersberger; Andrea Botomino; Maxime Mancini; Rudolf Bruppacher
Journal:  Pharm World Sci       Date:  2006-09-27

5.  Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance.

Authors:  W P James; A Astrup; N Finer; J Hilsted; P Kopelman; S Rössner; W H Saris; L F Van Gaal
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

6.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

7.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

8.  Time trends (1993-1997) and seasonal variation in body mass index and waist circumference in the Netherlands.

Authors:  T L S Visscher; J C Seidell
Journal:  Int J Obes Relat Metab Disord       Date:  2004-10

9.  Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

Authors:  L Sjöström; A Rissanen; T Andersen; M Boldrin; A Golay; H P Koppeschaar; M Krempf
Journal:  Lancet       Date:  1998-07-18       Impact factor: 79.321

10.  Effects of weight reduction interventions by community pharmacists.

Authors:  Renee A Ahrens; Matthew Hower; Al M Best
Journal:  J Am Pharm Assoc (2003)       Date:  2003 Sep-Oct
  10 in total
  9 in total

Review 1.  Review of services provided by pharmacies that promote healthy living.

Authors:  David Brown; Jane Portlock; Paul Rutter
Journal:  Int J Clin Pharm       Date:  2012-04-17

2.  What is the Role of the Pharmacist in Obesity Management?

Authors:  Katherine S O'Neal; Kimberly M Crosby
Journal:  Curr Obes Rep       Date:  2014-09

3.  Sequential screening for diabetes--evaluation of a campaign in Swiss community pharmacies.

Authors:  Kurt E Hersberger; Andrea Botomino; Maxime Mancini; Rudolf Bruppacher
Journal:  Pharm World Sci       Date:  2006-09-27

4.  Preventive counselling for public health in pharmacies in South Germany.

Authors:  Karin Schmiedel; Helmut Schlager; Frank Dörje
Journal:  Int J Clin Pharm       Date:  2012-11-06

Review 5.  The Effectiveness and Cost of Lifestyle Interventions Including Nutrition Education for Diabetes Prevention: A Systematic Review and Meta-Analysis.

Authors:  Yu Sun; Wen You; Fabio Almeida; Paul Estabrooks; Brenda Davy
Journal:  J Acad Nutr Diet       Date:  2017-03       Impact factor: 4.910

6.  Weight management in community pharmacy: what do the experts think?

Authors:  Irene S Um; Carol Armour; Ines Krass; Timothy Gill; Betty B Chaar
Journal:  Int J Clin Pharm       Date:  2013-03-02

7.  Community Pharmacists role in obesity treatment in Kuwait: a cross-sectional study.

Authors:  Abdelmoneim Awad; Mohammad Waheedi
Journal:  BMC Public Health       Date:  2012-10-11       Impact factor: 3.295

8.  Dietary Advice and Collaborative Working: Do Pharmacists and Allied Health Professionals Other Than Dietitians Have a Role?

Authors:  Jane McClinchy; Julia Williams; Lynne Gordon; Mindy Cairns; Gail Fairey
Journal:  Healthcare (Basel)       Date:  2015-02-12

9.  A community pharmacy weight management programme: an evaluation of effectiveness.

Authors:  David Morrison; Philip McLoone; Naomi Brosnahan; Louise McCombie; Andrea Smith; Janie Gordon
Journal:  BMC Public Health       Date:  2013-03-27       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.